Neostem (NBS) Misses Q3 EPS Views; Revs Light

November 11, 2011 7:32 AM EST
Neostem (AMEX: NBS) reported Q3 loss to controlling interests of ($0.13), $0.02 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $17.8 million versus the consensus estimate of $22.01 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings